
Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
Author(s) -
Amal Gad,
Eiji Tanaka,
Akihiro Matsumoto,
Moushira Abd-el Wahab,
Abd el-Hamid Serwah,
Fadia M. Attia,
Khalil Ali,
Howayda Hassouba,
A Eldeeb,
Tetsuya Ichijyo,
Takeji Umemura,
Hidetomo Muto,
Kaname Yoshizawa,
Kendo Kiyosawa
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i42.6607
Subject(s) - hepatocellular carcinoma , medicine , tumor marker , cirrhosis , gastroenterology , receiver operating characteristic , immunoassay , chronic liver disease , antibody , pathology , cancer , immunology
To investigate the clinical significance of KL-6 as a tumor marker of HCC in two different ethnic groups with chronic liver disease consecutively encountered at outpatient clinics.